Wyoming HB0164 allows prescribers to prescribe and pharmacists to dispense FDA-approved drugs for off-label indications, exempting them from.
Wyoming HB0164 permits prescribers to prescribe and pharmacists to dispense FDA-approved prescription drugs for off-label indications, provided the drugs are not controlled substances or intended for sex transition or affirmation in minors. This act also shields prescribers and pharmacists from disciplinary actions by health-related licensing boards for such practices. The Wyoming state board of medicine, the board of dental examiners, the board of nursing, and the state board of pharmacy are tasked with adopting necessary rules to implement this act, which takes effect July 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.